SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-029228
Filing Date
2022-11-09
Accepted
2022-11-09 16:11:45
Documents
74
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aadi-20220930.htm   iXBRL 10-Q 2027460
2 EX-31.1 aadi-20220930xex311.htm EX-31.1 11343
3 EX-31.2 aadi-20220930xex312.htm EX-31.2 11187
4 EX-32.1 aadi-20220930xex321.htm EX-32.1 5967
5 EX-32.2 aadi-20220930xex322.htm EX-32.2 5653
  Complete submission text file 0001628280-22-029228.txt   7828002

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aadi-20220930.xsd EX-101.SCH 53715
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aadi-20220930_cal.xml EX-101.CAL 69692
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aadi-20220930_def.xml EX-101.DEF 216140
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aadi-20220930_lab.xml EX-101.LAB 619892
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aadi-20220930_pre.xml EX-101.PRE 409649
68 EXTRACTED XBRL INSTANCE DOCUMENT aadi-20220930_htm.xml XML 1089892
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38560 | Film No.: 221372695
SIC: 2834 Pharmaceutical Preparations